-
Dr. Stanley T. Crooke, Founder, Chairman and CEO of n-Lorem Foundation Moderated by Fred Ledley Biopharmaceutical innovation requires both scientific breakthroughs and…
Fireside Chat: Leading Innovation with Impact -…
-
From Science to Public Value: How People and Policy Drive New Medicines
CISI Fireside Chat - Namandje Bumpus - 9/8/2025
-
Fireside Chat: Susan Windham-Bannister -…
-
Mitigation and Resilience
Mitigation and Resilience - Confronting the…
-
PhD Workshop
PhD Workshop - Confronting the Pandemic with…
-
Policies and Politics
Policies and Politics - Confronting the Pandemic…
-
Costs and Consequences
Costs and Consequences - Confronting the Pandemic…
-
Opening Session
Opening Session - Confronting the Pandemic with…
-
Dr. Jackson teaches human biology in the department of Natural and Applied Sciences. They quickly updated the course to reflect the pandemic during the spring semester…
Matthew Jackson: Redesigning human biology
-
Fred Ledley explains the Center for Integration of Science's current research around "the financing and public policy related to drug development" as it…
Fred Ledley: Financing, public policy & drug…
-
Matthew Jackson works in the Center for Integration of Science and Industry on the maturity of underlying basic research, funding and drug development. Dr. Jackson is…
Matthew Jackson: Underlying science, vaccines…
-
Dr. Edward J. Benz, Jr., MD, former president and CEO of Dana-Farber Cancer Institute talks about Dana Farber’s role in healthcare innovation and how this large…
Leading Innovation in a Time of Healthcare…
-
A fireside chat on the financialization of the pharmaceutical industry and its effects on drugs by Economist Dr. William Lazonick. The event is organized by the Center…
Innovation and Financialization in…
-
A fireside chat with Dr. Gary J. Nabel, M.D., Ph.D. Dr. Gary J. Nabel, M.D., Ph.D., is Chief Scientific Officer, Global Research and Development, and Head of the North…
Frugal Innovation Creating a Path to a Healthier…
-
Dr. Sharp will explore the dynamic intersections of science with business and public policy, and how these interactions advance the public interest. We are honored to…
From Basic Science to Biogen and Beyond -…
-
Ekaterina Cleary, Bentley research associate and lead author of the study; Deborah Dunsire, CEO of Xtuit Pharmaceuticals; Chris Garabedian, CEO of Xontogeny; Mark…
From Basic Science to Better Medicines: A…
-
Bentley alumnus Lance Colwell, and MIldon Farrwell, from Biogen, discuss the commercial launch of a revolutionary new product, Spiranza
Bringing New Medicines to Market - April 3, 2018
-
Stephen Bonner, former CEO & Director, Center Treatment Centers of America
Where Will You Find Opportunities in the…
Search for ""